The interactions between genes and the environment are now regarded as the most probable explanation for autism. In this review, we summarize the results of a metallomics study in which scalp hair concentrations of 26 trace elements were examined for 1,967 autistic children (1,553 males and 414 females aged 0–15 years-old), and discuss recent advances in our understanding of epigenetic roles of infantile mineral imbalances in the pathogenesis of autism. In the 1,967 subjects, 584 (29.7%) and 347 (17.6%) were found deficient in zinc and magnesium, respectively, and the incidence rate of zinc deficiency was estimated at 43.5% in male and 52.5% in female infantile subjects aged 0–3 years-old. In contrast, 339 (17.2%), 168 (8.5%) and 94 (4.8%) individuals were found to suffer from high burdens of aluminum, cadmium and lead, respectively, and 2.8% or less from mercury and arsenic. High toxic metal burdens were more frequently observed in the infants aged 0–3 years-old, whose incidence rates were 20.6%, 12.1%, 7.5%, 3.2% and 2.3% for aluminum, cadmium, lead, arsenic and mercury, respectively. These findings suggest that infantile zinc- and magnesium-deficiency and/or toxic metal burdens may be critical and induce epigenetic alterations in the genes and genetic regulation mechanisms of neurodevelopment in the autistic children, and demonstrate that a time factor “infantile window” is also critical for neurodevelopment and probably for therapy. Thus, early metallomics analysis may lead to early screening/estimation and treatment/prevention for the autistic neurodevelopment disorders.
References
[1]
Weintraub, K. Autism counts. Nature 2011, 479, 22–24.
[2]
Pinto, D.; Pagnamenta, A.T.; Klei, L.; Anney, R.; Merico, D.; Regan, R.; Conroy, J.; Magalhaes, T.R.; Correia, C.; Abrahams, B.S.; et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466, 368–372.
[3]
Chakrabarti, S.; Fombonne, E. Pervasive developmental disorders in preschool children: Confirmation of high prevalence. Amer. J. Psychiat. 2005, 162, 1133–1141, doi:10.1176/appi.ajp.162.6.1133.
[4]
Bailey, A.; le Couteur, A.; Gottesman, I.; Bolton, P.; Simonoff, E.; Yuzda, E.; Rutter, M. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol. Med. 1995, 25, 63–77, doi:10.1017/S0033291700028099.
[5]
Marshall, C.R.; Noor, A.; Vincent, J.B.; Lionel, A.C.; Feuk, L.; Skaug, J.; Shago, M.; Moessner, R.; Pinto, D.; Ren, Y.; et al. Structural variation of chromosomes in autism spectrum disorder. Amer. J. Hum. Genet. 2008, 82, 477–488, doi:10.1016/j.ajhg.2007.12.009.
[6]
Kim, S.J.; Silva, R.M.; Flores, C.G.; Jacob, S.; Guter, S.; Valcante, G.; Zaytoun, A.M.; Cook, E.H.; Badner, J.A. A quantitative association study of SLC25A12 and restricted repetitive behavior traits in autism spectrum disorders. Mol. Autism 2011, 2, doi:10.1186/2040-2392-2-8.
[7]
Murdoch, J.D.; State, M.W. Recent developments in the genetics of autism spectrum disorders. Curr. Opin. Genet. Dev. 2013, 23, 310–315, doi:10.1016/j.gde.2013.02.003.
[8]
Huguet, G.; Ey, E.; Bourgeron, T. The genetic landscapes of autism spectrum disorders. Ann. Rev. Genomics Hum. Genet. 2013, 14, 191–213, doi:10.1146/annurev-genom-091212-153431.
[9]
Hughes, V. Autism: Complex disorder. Nature 2012, 491, S2–S3, doi:10.1038/491S2a.
[10]
Dufault, R.; Schnoll, R.; Lukiw, W.J.; Leblanc, B.; Cornett, C.; Patrick, L.; Wallinga, D.; Gilbert, S.G.; Crider, R. Mercury exposure, nutritional deficiencies and metabolic disruption may affect learning in children. Behav. Brain Funct. 2009, 5, 44–58, doi:10.1186/1744-9081-5-44.
[11]
Palmer, R.F.; Blanchard, S.; Wood, R. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009, 15, 18–24, doi:10.1016/j.healthplace.2008.02.001.
[12]
Majewska, M.D.; Urbanowicz, E.; Rok-Bujko, P.; Namyslowska, I.; Mierzejewsky, P. Age-dependent lower or higher levels of hair mercury in autistic children than in healthy controls. Acta Neurobiol. Exp. 2010, 70, 196–208.
[13]
O’Rahilly, S. Human genetics illuminates the paths to metabolic disease. Nature 2009, 462, 307–314, doi:10.1038/nature08532.
[14]
James, S.J.; Shpyleva, S.; Melnyk, S.; Pavliv, O.; Pogribny, I.P. Complex epigenetic regulation of engrailed-2 (EN-2) homeobox gene in the autism cerebellum. Transl. Psychiat. 2013, 3, e232, doi:10.1038/tp.2013.8.
[15]
Jin, Y.H.; Clark, A.B.; Slebos, R.J.; Al-Refai, H.; Taylor, J.A.; Kunkel, T.A.; Resnick, M.A.; Gordenin, D.A. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat. Genet. 2003, 34, 239–241, doi:10.1038/ng0703-239.
[16]
Takiguchi, M.; Achanzar, W.E.; Qu, W.; Li, G.; Waalkes, M.P. Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 2003, 286, 355–365, doi:10.1016/S0014-4827(03)00062-4.
[17]
Arita, A.; Costa, M. Epigenetics in metal carcinogenesis: Nickel, arsenic, chromium and cadmium. Metallomics 2009, 1, 222–228, doi:10.1039/b903049b.
[18]
Perera, F.; Herbstman, J. Prenatal environmental exposure, epigenetics, and disease. Reprod. Toxicol. 2011, 31, 363–373, doi:10.1016/j.reprotox.2010.12.055.
[19]
Jakovcevski, M.; Akbarian, S. Epigenetic mechanisms in neurological disease. Nat. Med. 2012, 18, 1194–1204, doi:10.1038/nm.2828.
[20]
Ciesielski, T.; Weuve, J.; Bellinger, D.C.; Schwartz, J.; Lanphear, B.; Wright, R.O. Cadmium exposure and neurodevelopmental outcomes in U.S. children. Environ. Health Perspect. 2012, 120, 758–763, doi:10.1289/ehp.1104152.
[21]
Rodushkin, I.; Axelsson, M.D. Application of double focusing sector field ICP-MS for multi elemental characterization of human hair and nails. Part I. Analytical methodology. Sci. Total Environ. 2000, 250, 83–100, doi:10.1016/S0048-9697(00)00369-7.
[22]
Goulle, J.P.; Mahieu, L.; Castermant, J.; Neveu, N.; Bonneau, L.; Lainé, G.; Bouige, D.; Lacroix, C. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair: Reference values. Forensic Sci. Int. 2005, 153, 39–44, doi:10.1016/j.forsciint.2005.04.020.
[23]
Wang, C.T.; Chang, W.T.; Zeng, W.F.; Lin, C.H. Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan. Clin. Chem. Lab. Med. 2005, 43, 389–393.
[24]
Munakata, M.; Onuma, A.; Kobayashi, Y.; Haginoya, K.; Yokoyama, H.; Fujiwara, I.; Yasuda, H.; Tsutsui, T.; Iinuma, K. A preliminary analysis of trace elements in the scalp hair of patients with severe motor disabilities receiving enteral nutrition. Brain Dev. 2006, 28, 521–525, doi:10.1016/j.braindev.2006.02.004.
[25]
Yasuda, H.; Yonashiro, T.; Yoshida, K.; Ishii, T.; Tsutsui, T. Mineral imbalance in children with autistic disorders. Biomed. Res. Trace Elem. 2005, 16, 285–291.
[26]
Yasuda, H.; Yonashiro, T.; Yoshida, K.; Ishii, T.; Tsutsui, T. Relationship between body mass index and minerals in male Japanese adults. Biomed. Res. Trace Elem. 2006, 17, 316–321.
[27]
Yasuda, H.; Yoshida, K.; Segawa, M.; Tokuda, R.; Tsutsui, T.; Yasuda, Y.; Magara, S. Metallomics study using hair mineral analysis and multiple logistic regression analysis: Relationship between cancer and minerals. Environ. Health Prev. Med. 2009, 14, 261–266, doi:10.1007/s12199-009-0092-y.
[28]
Ochi, A.; Ishimura, E.; Tsujimoto, Y.; Kakiya, R.; Tabata, T.; Mori, K.; Tahara, H.; Shoji, T.; Yasuda, H.; Nishizawa, Y.; et al. Elemental concentrations in scalp hair, nutritional status and health-related quality of life in haemodialysis patients. Ther. Apher. Dial. 2012, 16, 127–133, doi:10.1111/j.1744-9987.2011.01043.x.
[29]
Yasuda, H.; Yonashiro, T.; Yoshida, K.; Ishii, T.; Tsutsui, T. High toxic metal levels in scalp hair of infants and children. Biomed. Res. Trace Elem. 2005, 16, 39–45.
[30]
Yasuda, H.; Yoshida, K.; Segawa, M.; Tokuda, R.; Yasuda, Y.; Tsutsui, T. High accumulation of aluminium in hairs of infants and children. Biomed. Res. Trace Elem. 2008, 19, 57–62.
[31]
Yasuda, H.; Yoshida, K.; Yasuda, Y.; Tsutsui, T. Two age-related accumulation profiles of toxic metals. Curr. Aging Sci. 2012, 5, 105–111, doi:10.2174/1874609811205020105.
[32]
Yasuda, H.; Yoshida, K.; Yasuda, Y.; Tsutsui, T. Infantile zinc deficiency: Association with autism spectrum disorders. Sci. Rep. 2011, 1, doi:10.1038/srep00129.
[33]
Yasuda, H.; Yasuda, Y.; Tsutsui, T. Estimation of autistic children by metallomics analysis. Sci. Rep. 2013, 3, ep01199, doi:10.1038/srep01199.
[34]
Landa, R.J. Diagnosis of autism spectrum disorders in the first 3 years of life. Nat. Clin. Pract. Neurol. 2008, 4, 138–147, doi:10.1038/ncpneuro0731.
Dufault, R.; Lukiw, W.J.; Crider, R.; Schnoll, R.; Wallinga, D.; Deth, R. A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States. Clin. Epigenetics 2012, 4, 6, doi:10.1186/1868-7083-4-6.
[40]
Grabrucker, A.M. A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders. Dev. Neurobiol. 2013, doi:10.1002/dneu.22089.
[41]
Fukada, T.; Yamasaki, S.; Nishida, K.; Murakami, M.; Hirano, T. Zinc homeostasis and signalling in health and diseases: Zinc signalling. J. Biol. Inorg. Chem. 2011, 16, 1123–1134, doi:10.1007/s00775-011-0797-4.
[42]
Andreini, C.; Banci, L.; Bertini, I.; Rosato, A. Counting the zinc-proteins encoded in the human genome. J. Proteome Res. 2006, 5, 196–201, doi:10.1021/pr050361j.
[43]
Takeda, A. Movement of zinc and its functional significance in the brain. Brain Res. Rev. 2000, 34, 137–148, doi:10.1016/S0165-0173(00)00044-8.
[44]
Takeda, A.; Nakamura, M.; Fujii, H.; Tamano, H. Synaptic Zn(2+) homeostasis and its significance. Metallomics 2013, 5, 417–423, doi:10.1039/c3mt20269k.
[45]
Prasad, A.S. Impact of the discovery of human zinc deficiency on health. J. Am. Coll. Nutr. 2009, 28, 257–265, doi:10.1080/07315724.2009.10719780.
[46]
Arnold, L.E.; di Silvestro, R.A. Zinc in attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 2005, 15, 619–627, doi:10.1089/cap.2005.15.619.
[47]
di Girolamo, A.M.; Raminez-Zea, M. Role of zinc in maternal and child mental health. Amer. J. Clin. Nutr. 2009, 89, S940–S945, doi:10.3945/ajcn.2008.26692C.
[48]
Scheplyagina, L.A. Impact of the mother’s zinc deficiency on the woman’s and new-borns health status. J. Trace Elem. Med. Biol. 2005, 19, 29–35, doi:10.1016/j.jtemb.2005.07.008.
[49]
Plum, L.M.; Rink, L.; Haase, H. The essential toxin: Impact of zinc on human health. Int. J. Environ. Res. Public Health 2010, 7, 1342–1365, doi:10.3390/ijerph7041342.
[50]
Yorbik, O.; Akay, C.; Sayal, A.; Cansever, A.; Sohmen, T.; Cavdar, A.O. Zinc status in autistic children. J. Trace Elem. Exp. Med. 2004, 17, 101–107, doi:10.1002/jtra.20002.
[51]
Fido, A.; Al-Saad, S. Toxic trace elements in the hair of children with autism. Autism 2005, 9, 290–298, doi:10.1177/1362361305053255.
[52]
Adams, J.B.; Holloway, C.E.; George, F.; Quig, D. Analyses of toxic metals and essential minerals in the hair of Arizona children with autism and associated conditions, and their mothers. Biol. Trace Elem. Res. 2006, 110, 193–209, doi:10.1385/BTER:110:3:193.
[53]
Faber, S.; Zinn, G.M.; Kern, J.C.; Kingston, H.M. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 2009, 14, 171–180, doi:10.1080/13547500902783747.
[54]
Priya, M.D.L.; Geetha, A. Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol. Trace Elem. Res. 2011, 142, 148–158, doi:10.1007/s12011-010-8766-2.
[55]
Gebremedhin, S.; Enquselassie, F.; Umeta, M. Prevalence of prenatal zinc deficiency and its association with socio-demographic, dietary and health care related factors in Rural Sidama, Southern Ethiopia: A cross-sectional study. BMC Public Health 2011, 11, 898–907, doi:10.1186/1471-2458-11-898.
[56]
Kurita, H.; Ohsako, S.; Hashimoto, S.; Yoshinaga, J.; Tohyama, C. Prenatal zinc deficiency-dependent epigenetic alterations of mouse metallothionein-2 gene. J. Nutr. Biochem. 2013, 24, 256–266, doi:10.1016/j.jnutbio.2012.05.013.
[57]
Arnold, L.E.; Bozzolo, H.; Hollway, J.; Cook, A.; di Silvestro, R.A.; Bozzolo, D.R.; Crowl, L.; Ramadan, Y.; Williams, C. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. J. Child Adoles. Psychopharmacol. 2005, 15, 628–636, doi:10.1089/cap.2005.15.628.
[58]
Yorbik, O.; Ozdag, M.F.; Olgun, A.; Senol, M.G.; Bek, S.; Akman, S. Potential effects of zinc on information processing in boys with attention deficit hyper-activity disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 662–667, doi:10.1016/j.pnpbp.2007.11.009.
[59]
di Girolamo, A.M.; Ramirez-Zea, M.; Wang, M.; Flores-Ayala, R.; Martorell, R.; Neufeld, L.M.; Ramakrishnan, U.; Sellen, D.; Black, M.M.; Stein, A.D. Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala. Am. J. Clin. Nutr. 2010, 92, 1241–1250, doi:10.3945/ajcn.2010.29686.
[60]
Akhondzadeh, S.; Mohammadi, M.R.; Khademi, M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomised trial [ISRCTN64132371]. BMC Psychiatry 2004, 4, 9–14, doi:10.1186/1471-244X-4-9.
[61]
Kozielec, T.; Starobrat-Hermelin, B. Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes. Res. 1997, 10, 143–148.
[62]
Starobrat-Hermelin, B.; Kozielec, T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes. Res. 1997, 10, 149–156.
[63]
Mousain-Bose, M.; Roche, M.; Rapin, J.; Bali, J.P. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J. Amer. Coll. Nutr. 2004, 23, S545–S548, doi:10.1080/07315724.2004.10719400.
[64]
Mousain-Bose, M.; Roche, M.; Polge, A.; Pradal-Prat, D.; Rapin, J.; Bali, J.P. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitanin B6 II. Pervasive developmental disorder-autism. Magnes. Res. 2006, 19, 53–62.
[65]
Ochi, A.; Ishimura, E.; Tsujimoto, Y.; Kakiya, R.; Tabata, T.; Mori, K.; Fukumoto, S.; Tahara, H.; Shoji, T.; Yasuda, H.; et al. Hair magnesium, but not serum magnesium, is associated with left ventricular wall thickness in hemodialysis patients. Circ. J. 2013, doi:10.1253/circj.CJ-13-0347.
[66]
Dufner-Beattie, J.; Kuo, Y.M.; Gitschier, J.; Andrews, G.K. The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc regulation of the zinc transporters ZIP4 and ZIP5. J. Biol. Chem. 2004, 279, 49082–49090, doi:10.1074/jbc.M409962200.
[67]
Lichten, L.A.; Cousins, R.J. Mammalian zinc transporters: Nutritional and physiologic regulation. Ann. Rev. Nutr. 2009, 29, 153–176, doi:10.1146/annurev-nutr-033009-083312.
[68]
Goyer, R.A. Toxic and essential metal interactions. Ann. Rev. Nutr. 1997, 17, 37–50, doi:10.1146/annurev.nutr.17.1.37.
[69]
Mahaffey, K.R.; Gartside, P.S.; Glueck, C.J. Blood lead levels and dietary calcium intake in 1 to 11 year-old children: The second national health and nutrition examination survey, 1976 to 1980. Pediatrics 1986, 78, 257–262.
[70]
Shannon, M.; Graef, J.W. Lead intoxication in children with pervasive developmental disorders. J. Toxicol. Clin. Toxicol. 1996, 34, 177–181, doi:10.3109/15563659609013767.
[71]
Eubig, P.A.; Agular, A.; Schantz, S.L. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ. Health Perspect. 2010, 118, 1654–1667, doi:10.1289/ehp.0901852.
[72]
Centers for Disease Control and Prevention (CDC). CDC National Surveillance Data (1997–2009), National Centers for Environmental Health 2012. Available online: http://www.cdc.gov/nceh/lead/data/national.htm. (accessed on 6 November 2013).
[73]
Jones, R.L.; Homa, D.M.; Meyer, P.A.; Brody, D.J.; Caldwell, K.L.; Pirkle, J.L.; Brown, M.J. Trends in blood lead levels and blood testing among US children aged 1 to 5 years, 1988–2004. Pediatrics 2009, 123, 376–385, doi:10.1542/peds.2007-3608.
[74]
Advisory Committee on Childhood Lead Poisoning Prevention, of the Centers for Disease Control and Prevention. Low Level Lead Exposure Harms Children: A Renewed Call for Primary Prevention: Report to the CDCP; ACCLPP: Atlanta, GA, USA, 2012; pp. 1–54.
[75]
Needleman, H.L.; Schell, A.; Bellinger, D.; Leviton, A.; Allred, E.N. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow up report. N. Engl. J. Med. 1990, 322, 83–88, doi:10.1056/NEJM199001113220203.
[76]
Binns, H.J.; Campbell, C.; Brown, M.J. Interpreting and managing blood lead levels of less than 10 micro g/dL in children and reducing childhood exposure to lead: Recommendations of the centers for disease control and prevention advisory committee on childhood lead poisoning prevention. Pediatrics 2007, 120, e1285–e1298, doi:10.1542/peds.2005-1770.
[77]
Bellinger, D.C. Lead neurotoxicity and socioeconomic status: Conceptual and analytical issues. Neurotoxicology 2008, 29, 828–832, doi:10.1016/j.neuro.2008.04.005.
[78]
Gump, B.B.; Stewart, P.; Reihman, J.; Lonky, E.; Darvill, T.; Parsons, P.J.; Granger, D.A. Low-level prenatal and postnatal blood lead (Pb) exposure and adrenocortical responses to acute stress in children. Environ. Health Perspect. 2008, 116, 249–255.
[79]
Nigg, J.T.; Knottnerus, G.M.; Martel, M.M.; Nikoas, M.; Cavanagh, V.; Karmaus, W.; Rappley, M.D. Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biol. Psychiatry 2008, 63, 325–331, doi:10.1016/j.biopsych.2007.07.013.
[80]
Dixon, S.L.; Gaitens, J.M.; Jacobs, D.E.; Strauss, W.; Nagaraja, L.; Pivetz, T.; Wilson, J.W.; Ashley, P.J. Exposure of U.S. children to residential dust lead, 1999–2004: II. The contribution of lead-contaminated dust to children’s blood lead levels. Environ. Health Perspect. 2009, 117, 468–474.
[81]
American Academy of Pediatrics. Lead exposure in children: Prevention, detection, and management: Statement of policy reaffirmation. Psychiatry 2009, 123, 1421–1422.
[82]
Deocampo, D.M.; Reed, P.J.; Kalenuik, A.P. Road dust lead (Pb) in two neighbourhoods of urban Atlanta, (GA, USA). Int. J. Environ. Res. Public Health 2012, 9, 2020–2030, doi:10.3390/ijerph9062020.
[83]
Hall, G.; Tinklenberg, J. Determination of Ti, Zn, and Pb in lead-based house paints by EDXRF. J. Anal. At. Spectrom. 2003, 18, 775–778, doi:10.1039/b300597f.
[84]
Lewis, P.A. Inorganic Colored Pigments. In Paint and Coating Testing Manual, 14th ed.; Koleske, J.V., Ed.; ASTM: West Conshohocken, PA, USA, 1995; pp. 1–950.
[85]
Symanski, E.; Hertz-Picciotto, I. Blood lead levels in relation to menopause, smoking, and pregnancy history. Amer. J. Epidemiol. 1995, 141, 1047–1058.
[86]
Razagui, I.B.; Ghribi, I. Maternal and neonatal scalp hair concentrations of zinc, cadmium, and lead: Relationship to some lifestyle factors. Biol. Trace Elem. Res. 2005, 106, 1–28, doi:10.1385/BTER:106:1:001.
[87]
Gulson, B.L.; Jameson, C.W.; Mahaffey, K.R.; Mizon, K.J.; Korsch, M.J.; Vimpani, G. Pregnancy increases mobilization of lead from maternal skeleton. J. Lab. Clin. Med. 1997, 130, 51–62, doi:10.1016/S0022-2143(97)90058-5.
[88]
Sanders, A.P.; Flood, K.; Chiang, S.; Herring, A.H.; Wolf, L.; Fry, R.C. Towards prenatal biomonitoring in North Carolina: Assessing arsenic, cadmium, mercury and lead levels in pregnant women. PLoS One 2012, 7, e31354, doi:10.1371/journal.pone.0031354.
[89]
Parajuli, R.P.; Fujiwara, T.; Umezaki, M.; Watanabe, C. Association of cord blood levels of lead, arsenic, and zinc with neurodevelopmental indicators in newborns: A birth cohort study in Chitwan Valley, Nepal. Environ. Res. 2012, 10, 509–519.
